ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

January 29, 1993

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007